{"id":837348,"date":"2025-04-15T08:14:05","date_gmt":"2025-04-15T12:14:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/"},"modified":"2025-04-15T08:14:05","modified_gmt":"2025-04-15T12:14:05","slug":"processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/","title":{"rendered":"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025"},"content":{"rendered":"
\n

\n HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA)<\/strong>\u00a0(Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced that Dr. David Young, Founder and President of Research & Development, has been invited to present at the World Orphan Drug Congress USA 2025.<\/p>\n

Dr. Young\u2019s presentation, titled \u201cApplying Principles of FDA\u2019s Project Optimus to Oncology and Non-Oncology Rare Diseases,\u201d<\/em> will take place on Tuesday, April 24, 2025, at 2:00 p.m. Eastern Time at the Boston Convention & Exhibition Center.<\/p>\n

Dr. Young\u2019s presentation will explore how the principles of FDA\u2019s Project Optimus initiative \u2014 particularly determining the optimal dose to improve the balance of efficacy and safety \u2014 can be used for the FDA approval of drugs to treat rare oncology and rare non-oncology diseases. This approach is core to Processa\u2019s Regulatory Science approach, which focuses on improving therapies through regulatory science to deliver better outcomes for patients.<\/p>\n

For more information about World Orphan Drug Congress USA 2025, please click\u00a0here<\/a>.<\/p>\n

\n About Processa Pharmaceuticals, Inc.<\/strong>\n <\/p>\n

Processa is a clinical-stage pharmaceutical company focused on developing the Next Generation Cancer (NGC) drugs with improved safety and efficacy. Processa\u2019s NGC drugs are modifications of existing FDA-approved oncology therapies resulting in an alteration of the metabolism and\/or distribution of these drugs while maintaining the existing mechanisms of killing the cancer cells. By combining its novel oncology pipeline with proven cancer-killing active molecules and its Regulatory Science Approach, Processa\u2019s strategy is to develop more effective therapy options with improved tolerability for cancer patients through an efficient regulatory path.<\/p>\n

For more information, visit our website at\u00a0www.processapharma.com<\/a>.<\/p>\n

\n Company\u00a0Contact:<\/strong>
\n
Patrick Lin
(925) 683-3218
plin@processapharma.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA)\u00a0(Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced that Dr. David Young, Founder and President of Research & Development, has been invited to present at the World Orphan Drug Congress USA 2025. Dr. Young\u2019s presentation, titled \u201cApplying Principles of FDA\u2019s Project Optimus to Oncology and Non-Oncology Rare Diseases,\u201d will take place on Tuesday, April 24, 2025, at 2:00 p.m. Eastern Time at the Boston Convention & Exhibition Center. Dr. Young\u2019s presentation will explore how the principles of FDA\u2019s Project Optimus initiative \u2014 particularly determining the optimal dose to improve the balance of efficacy … <\/p>\n

Continue reading “Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837348","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProcessa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA)\u00a0(Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced that Dr. David Young, Founder and President of Research & Development, has been invited to present at the World Orphan Drug Congress USA 2025. Dr. Young\u2019s presentation, titled \u201cApplying Principles of FDA\u2019s Project Optimus to Oncology and Non-Oncology Rare Diseases,\u201d will take place on Tuesday, April 24, 2025, at 2:00 p.m. Eastern Time at the Boston Convention & Exhibition Center. Dr. Young\u2019s presentation will explore how the principles of FDA\u2019s Project Optimus initiative \u2014 particularly determining the optimal dose to improve the balance of efficacy … Continue reading "Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T12:14:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025\",\"datePublished\":\"2025-04-15T12:14:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/\"},\"wordCount\":300,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/\",\"name\":\"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==\",\"datePublished\":\"2025-04-15T12:14:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/","og_locale":"en_US","og_type":"article","og_title":"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025 - Market Newsdesk","og_description":"HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA)\u00a0(Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, today announced that Dr. David Young, Founder and President of Research & Development, has been invited to present at the World Orphan Drug Congress USA 2025. Dr. Young\u2019s presentation, titled \u201cApplying Principles of FDA\u2019s Project Optimus to Oncology and Non-Oncology Rare Diseases,\u201d will take place on Tuesday, April 24, 2025, at 2:00 p.m. Eastern Time at the Boston Convention & Exhibition Center. Dr. Young\u2019s presentation will explore how the principles of FDA\u2019s Project Optimus initiative \u2014 particularly determining the optimal dose to improve the balance of efficacy … Continue reading \"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-15T12:14:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025","datePublished":"2025-04-15T12:14:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/"},"wordCount":300,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/","name":"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==","datePublished":"2025-04-15T12:14:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjM0MSM2ODY2NDA5IzUwMDA0NjUzNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/processa-pharmaceuticals-dr-david-young-to-present-at-world-orphan-drug-congress-usa-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Processa Pharmaceuticals\u2019 Dr. David Young to Present at World Orphan Drug Congress USA 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837348"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837348\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}